Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
May 03 2021 - 4:30PM
Business Wire
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine
company, announced today that management will be participating in
fireside chats at the following investor conferences:
- BofA Securities 2021 Health Care Conference Date:
Thursday, May 13th at 1:15 p.m. Eastern Time
- 2021 RBC Capital Markets Global Healthcare Conference
Date: Tuesday, May 18th at 9:45 a.m. Eastern Time
For presentations that are webcast live, an access link will be
available on the Sangamo Therapeutics website in the Investors and
Media section under Events and Presentations. The presentations
will also be available on the Sangamo Therapeutics website after
the event.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking
science into genomic medicines with the potential to transform
patients’ lives using gene therapy, cell therapy, and genome
engineering. For more information about Sangamo, visit
www.sangamo.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210503005585/en/
Investor Relations & Media
Inquiries Aron Feingold 628.252.7494
afeingold@sangamo.com
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Sep 2023 to Sep 2024